Učitavanje...
PATH-53. EXPRESSION BASED INTRINSIC GLIOMA SUBTYPES ARE PROGNOSTIC IN LOW GRADE GLIOMAS OF THE EORTC22033-26033 CLINICAL TRIAL
INTRODUCTION: The EORTC22033-26033 clinical trial investigated whether initial temozolomide (TMZ) chemotherapy confers a survival advantage compared to radiotherapy (RT) in high-risk low-grade glioma patients. The aim of this study was to identify markers associated with survival and treatment respo...
Spremljeno u:
| Izdano u: | Neuro Oncol |
|---|---|
| Glavni autori: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692010/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.742 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|